Document is current
Any future updates will be listed below
-
Authors
Wang, Lingling
Hui, Hui
Agrawal, Kriti
Kang, Yuqi
Li, Na
Tang, Rachel https://orcid.org/0000-0003-0364-6280
Yuan, Jiajun
Rana, Tariq M https://orcid.org/0000-0001-9558-5766
-
Funding
Funding for this research was provided by:
National Institutes of Health SIG (S10 OD026929)
National Institutes of Health (DA046171)
National Cancer Institute (CA177322)
HHS|NIH|National Institute on Drug Abuse (DA039562)
HHS|NIH|National Institute of Allergy and Infectious Diseases (AI125103)
- License Information
-
More Information
Article History
Received: 19 January 2020
Revised: 29 July 2020
Accepted: 7 August 2020
First Online: 23 September 2020
Conflict of interest
: T.M.R. is a founder of ViRx Pharmaceuticals and has an equity interest in the company. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.
